10% PROMISSORY NOTERegen BioPharma Inc • September 18th, 2023 • Pharmaceutical preparations • Nevada
THIS IS A 10% PROMISSORY NOTE of Regen Biopharma, Inc., a Nevada corporation (the “Company”), having its principal place of business at 4700 Spring Street suite 304 La Mesa, CA 91942 (this “Note”), which represents a duly authorized and validly issued debt of the Company.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 18th, 2023 • Regen BioPharma Inc • Pharmaceutical preparations • Nevada
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of September 12, 2023, between REGEN BIOPHARMA, INC, a Nevada corporation (the “Company”), and Coventry Enterprises, LLC, a Delaware limited liability company (“Investor”).
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • September 18th, 2023 • Regen BioPharma Inc • Pharmaceutical preparations • Nevada
This Common Stock Purchase Agreement (the “Agreement”) is entered into as of September 12, 2023 by and between REGEN BIOPHARMA INC., a Nevada corporation (the “Company”), and COVENTRY ENTERPRISES, LLC, a Delaware limited liability company (the “Investor”). The Company and Investor may be referred to herein as each a “Party” and collectively, the “Parties”.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 18th, 2023 • Regen BioPharma Inc • Pharmaceutical preparations • Nevada
This Registration Rights Agreement (this “Agreement”), dated as of September 12, 2023, by and between Regen Biopharma, Inc., a Nevada corporation (the “Company”), and Coventry Enterprises, LLC, a Delaware limited liability company (together with it permitted assigns, the “Investor”) (the Company and Investor each a “Party” and together the “Parties”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Common Stock Purchase Agreement by and between the Parties, dated as of the date hereof (as amended, restated, supplemented, or otherwise modified from time to time, the “Purchase Agreement”).
